Scarica l'app Stockscreener
11.26
1.05%
-0.12
Dopo l'orario di chiusura:
11.50
0.24
+2.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OCUL Giù?
Forum
Previsione
Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie
Is Ocular Therapeutix Inc. (0OT) stock among top earnings playsTrade Risk Summary & Verified Stock Trade Ideas - ulpravda.ru
Biotech outperformance expected to continue in 2026, Baird analysts say - Proactive financial news
Ocular Therapeutix, Inc.'s (NASDAQ:OCUL) Stock Retreats 29% But Revenues Haven't Escaped The Attention Of Investors - Sahm
Published on: 2026-01-09 05:26:20 - ulpravda.ru
Published on: 2026-01-09 03:37:07 - ulpravda.ru
How Ocular Therapeutix Inc. stock reacts to job market dataCPI Data & Verified Entry Point Detection - ulpravda.ru
Is It Too Late To Consider Ocular Therapeutix (OCUL) After Recent Share Price Volatility? - Yahoo Finance
Assessing Ocular Therapeutix (OCUL) Valuation After Mixed Short-Term Weakness And Multi-Year Shareholder Gains - Sahm
Ocular Therapeutix, Inc. (OCUL) Investor Outlook: Unpacking The 109% Potential Upside - DirectorsTalk Interviews
RSI Check: How robust is Star Equity Holdings Inc FDV0 stock financial positionMarket Risk Analysis & Weekly Breakout Opportunity Watchlist - moha.gov.vn
The Technical Signals Behind (OCUL) That Institutions Follow - Stock Traders Daily
OCUL News Today | Why did Ocular Therapeutix stock go down today? - MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) Surprises With Q3 CY2025 Sales - Yahoo Finance
What to keep an eye on in 2026 - Eyes On Eyecare
BofA Bullish on Ocular Therapeutix (OCUL) as AXPAXLI Targets Superiority Label and Faster Regulatory Path in Wet AMD - Finviz
Fat Pitch FinancialsOcular Therapeutix, Inc.Common Stock (Nasdaq:OCUL) Stock Quote - FinancialContent
Ocular Therapeutix announces first patient randomized in HELIOS-3 program - MSN
Ocular Therapeutix Earnings Notes - Trefis
Voya Investment Management LLC Trims Position in Ocular Therapeutix, Inc. $OCUL - MarketBeat
Assenagon Asset Management S.A. Sells 148,100 Shares of Ocular Therapeutix, Inc. $OCUL - MarketBeat
Ocular Therapeutix (NASDAQ:OCUL) Share Price Crosses Above 50 Day Moving AverageWhat's Next? - MarketBeat
Trading Systems Reacting to (OCUL) Volatility - Stock Traders Daily
Revenue per share of Ocular Therapeutix Inc – BER:0OT - TradingView — Track All Markets
Is Ocular Therapeutix (NASDAQ:OCUL) Using Too Much Debt? - 富途牛牛
Aug Action: Is Ocular Therapeutix Inc. (0OT) stock among top earnings playsMarket Sentiment Report & High Yield Stock Recommendations - Улправда
What is the fair value of Ocular Therapeutix Inc. stock nowTrade Volume Report & Long Hold Capital Preservation Plans - ulpravda.ru
Can Ocular Therapeutix Inc. stock hit analyst price targetsMarket Performance Recap & Capital Protection Trade Alerts - ulpravda.ru
Is Ocular Therapeutix Inc. (0OT) stock worth buying before Fed action2025 Top Gainers & Verified Short-Term Plans - ulpravda.ru
Volume Summary: What is the fair value of Ocular Therapeutix Inc. stock now - ulpravda.ru
Can Ocular Therapeutix Inc. (0OT) stock retain market dominanceEarnings Recap Summary & Weekly Stock Performance Updates - DonanımHaber
What makes Ocular Therapeutix Inc. stock attractive to growth funds2025 Market WrapUp & Real-Time Market Sentiment Reports - DonanımHaber
Why analysts raise outlook for Ocular Therapeutix Inc. (0OT) stock2025 Pullback Review & Community Trade Idea Sharing Platform - Улправда
Ocular Therapeutix (OCUL) Is Down 10.9% After Pivoting AXPAXLI To Single-Trial NDA Pathway – Has The Bull Case Changed? - simplywall.st
Is Ocular Therapeutix Inc. stock in correction or buying zoneQuarterly Profit Report & Smart Swing Trading Alerts - Улправда
How Ocular Therapeutix Inc. stock benefits from global expansion2025 Fundamental Recap & Community Verified Trade Alerts - Улправда
Will Ocular Therapeutix Inc. stock reach all time highs in 2025Trade Risk Assessment & Stepwise Swing Trade Plans - ulpravda.ru
Ocular Therapeutix (NASDAQ:OCUL) Stock Price Down 4.3%What's Next? - MarketBeat
Assessing Ocular Therapeutix (OCUL) Valuation After Accelerated FDA Filing Plan for AXPAXLI in Wet AMD - Sahm
Ocular Therapeutix Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Ocular Therapeutix stock could see 45% upside if trial succeeds, TD Cowen says - Investing.com Canada
RBC Capital Adjusts Ocular Therapeutix Price Target to $24 From $17, Maintains Outperform Rating - marketscreener.com
Ocular Therapeutix prepares NDA submission for wet AMD drug - MSN
Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Ocular Therapeutix (OCUL) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Avoiding Lag: Real-Time Signals in (OCUL) Movement - news.stocktradersdaily.com
Ocular Therapeutix Inc. (OCUL) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
H.C. Wainwright Lifts Ocular Therapeutix, Inc. (OCUL) Price Target Following Intravitreal Implant FDA Submission - Insider Monkey
15 Best Biotech Stocks to Buy According to Wall Street Analysts - Insider Monkey
Chardan Capital Maintains Ocular Therapeutix (OCUL) Buy Recommendation - Nasdaq
Ocular Therapeutix (OCUL) Hits 4-Year High on Axpaxli NDA Application - Insider Monkey
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):